Manufactures chemicals

Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Kastle Therapeutics is to help underserved patients who have significantly unmet medical needs. They strive to support quality of care for patients with severe diseases. They work hard to solve challenges for therapeutic developers and manufacturers.

Rhone Poulenc Rorer, a subsidiary of Solvay SA, is a French company that manufactures and distributs pharmaceutical products.

Esperion Therapeutics, Inc. is a pharmaceutical company. It engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Savient Pharmaceuticals is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA™ (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP"). Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA. Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S.

Jilin Shengyuan Technology Co., Ltd., established on 1999-01-13, Business scope includes biochemistry,Research and development of scientific and technological projects such as genetic engineering,technology transfer,technical consulting,vegetable,grape growing*

MIBR is developing treatments and vaccines for rare diseases, autoimmune diseases, infectious diseases, cancers, etc. novel drug development using artificial intelligence pursuing the goals of developing new drugs and improving public health on a global scale

Ambrx is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. These include next generation antibody drug conjugates (ADCs), bispecifics, targeted immuno-oncology therapies, novel cytokines to modulate the immune system, and long-acting therapeutic peptides for metabolic and cardiovascular disease. Ambrx is advancing a robust portfolio of clinical and preclinical programs designed to optimize efficacy, safety and ease of use, in multiple therapeutic areas, including its lead product candidate ARX788.

DiaSys Diagnostic Systems (Shanghai) Co. Ltd., part of Beijing Leadman Biochemistry Co., Ltd., is a Chinese company located in Shanghai that engages in researches and develops medical products. The firm was founded in 1999. DiaSys Diagnostic Systems (Shanghai) Co. Ltd. was acquired by Beijing Leadman Biochemistry Co., Ltd. on July 09, 2015 for $60.51 million.

The Pasteur Institute of Lille (French: Institut Pasteur de Lille, Pasteur-Lille, IPL) is a research centre and member of the Pasteur Institute network. It includes 14 research units and 1,150 employees including 626 researchers located in Lille, France. There are also 300 employees located outside the Pasteur site. Its revenues are above €70 million. Several neuroscience start-up companies have emerged from the Pasteur Institute of Lille.

International Genetic Engineering, Inc. is a private company headquartered in Santa Monica, CA. The firm provides engineering services. It was founded by Gary L. Wilcox.

Pieris Pharmaceuticals GmbH, part of Pieris Pharmaceuticals, Inc., is a company headquartered in Hallbergmoos, Germany. The firm operates as a biotechnology company. Stephen S. Yoder and Hitto Kaufmann are the current co-CEOs of the firm.

Weifang Sunway Bioengineering Group Co., Ltd., established on 1997-03-26, Business scope includes production,Sales:Enzyme immunodiagnostic reagents,In Vitro Radiodiagnostic Reagents(The validity period is subject to the license);Production,Sales:II,Class III clinical laboratory analysis instrument(6840),Class II medical laboratory and basic equipment(6841)(The validity period is subject to the license).Production,Sales:Biological high-tech products and related supporting instruments;Import and export of goods and technologies permitted by the state.Own house rental;own equipment,Instrument rental.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Medicalsystem Biotechnology is a life science firm that is involved in the production, distribution, and manufacture of diagnostic goods. It offers medical facilities in-vitro biochemical diagnostic reagents. They supply customers with integrated IVD solutions. In the future, it will manufacture automated biochemical analyzers, hematological analyzers, and POCT analyzers in addition to offering biochemistry supplies.